ARTICLES BY THIS AUTHOR
- 1/19/2022
Walgreens, VillageMD bring clinics to Tucson, Ariz.
The eight clinic openings represent an expansion into Arizona’s second major market and add to the growing number of locations in the state, the companies said. - 1/19/2022
FDA green-lights Alembic’s generic Comtan
Entacapone tablets have a market value of roughly $10.5 million for the 12 months ending September 2021. - 1/18/2022
CVS Health, Uber to provide transportation for individuals in underserved communities
The collaboration, part of the retailer’s Health Zones initiative, will provide transportation support at no cost to individuals seeking access to medical care, work or educational programs. - 1/18/2022
Lupin obtains FDA approval, tentative OK for 2 generics
The Food and Drug Administration approved Lupin’s sevelamer carbonate for oral suspension and gave tentative approval for azilsartan medoxomil tablets. - 1/18/2022
Walgreens intros COVID-19 Index tracking activity by state
Data captured in the Walgreens COVID-19 Index tracks existing and emerging variants. - 1/17/2022
AbbVie obtains FDA nod for new indication of Rinvoq
Rinvoq is now approved for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 years old and older whose disease did not respond to previous treatment. - 1/17/2022
Breaking down barriers: Retail pharmacy is becoming a force in an unexpected area — providing mental health services
The rewards accrued from offering mental health services can be substantial in terms of clinical outcomes, customer satisfaction and retention, and improved revenue. - 1/17/2022
Glenmark Specialty S.A. receives FDA green light for Ryaltris
Ryaltris will be marketed and distributed through Glenmark’s partner Hikma Specialty. - 1/17/2022
Unilever’s rejected offer for GSK consumer healthcare reportedly raises questions
The bid for GSK’s assets, including Sensodyne toothpaste and Advil painkillers, comes as Unilever is dealing with steep inflation and sluggish growth in emerging markets. - 1/17/2022
ParaPro offers Natroba for new indication
Natroba provides a topical treatment for scabies infestations in adult and pediatric patients four years of age and older.